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Abstract 
It has been suggested that individual differences in cortical excitability leading to disruption 
of the timing and integration of sensory information processing may explain why some 
people have out of body experiences (OBE) in the absence of any known pathological or 
psychiatric condition. Here we recorded EEG from people who either had, or had not 
experienced an OBE in order to investigate the neural dynamics of OBE in the non-clinical 
population. A screening questionnaire was completed by 551 people, 24% of whom 
reported having at least one OBE. Participants who were free of any psychiatric or 
neurological diagnoses, including migraines, were invited to take part in subsequent EEG 
recording. EEG data were obtained from 19 people who had had an OBE and 20 who had 
not. Amplitude of the visual P1 ERP deflection and consistency of alpha-band phase locking 
were significantly reduced in the participants who had had an OBE. We did not find any 
group differences in resting state power or in visually induced gamma oscillations. These 
results provide support for the claim that cortical differences, particularly with respect to 
the timing of visual information processing, may give rise to OBE in clinically healthy 
individuals.  To our knowledge, this study is the first to compare EEG variables obtained 
from people who have, and have not, had an OBE.  
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1. Introduction 
Out-of-body experiences (OBE) are hallucinatory states during which people experience 
their centre of awareness as located outside of their physical body. Blanke and Arzy (2005) 
describe three phenomenological characteristics of OBE: disembodiment; the impression of 
seeing the world from a distant and elevated visuo-spatial perspective; and the experience 
of seeing one’s own body from this elevated visual perspective. OBE have been associated 
with vestibular dysfunction (Lopez & Elzière, 2017) and neurological conditions such as 
epilepsy and seizures (Devinsky, Feldmann, Burrowes & Bromfield, 1989).  OBE can be 
induced by stimulation of the temporoparietal junction (TPJ, Bos, Spoor, Smits, Schouten, & 
Vincent, 2016), and as such, one cause of OBE is considered to be a failure of multisensory 
integrative processes at the TPJ (Blanke & Arzy, 2005; Blanke et al., 2005). 
A number of studies have reported that OBE also occur in the absence of clear medical, 
pharmacological or psychological correlates (Alvarado, 2000). The incidence of spontaneous 
OBE in the general population appears to be approximately 10%. For example, from a 
selection of 321 individuals on the electoral register, 12% of respondents identified that 
they had experienced at least one OBE (Blackmore, 1984). Studies that have recruited 
clinically healthy University students as participants have reported OBE occurrence in 26% 
(Braithwaite, Samson, Apperly, Broglia, & Hulleman, 2011), 22% (Braithwaite, Broglia, 
Bagshaw, & Wilkins, 2013) and 10% of the samples (Braithwaite et al., 2013). In a more 
recent study, occurrence of OBE was assessed in patients who had been referred to an 
ontoneurological clinic for assessment of dizziness and vertigo, and a matched control group 
with no clinical symptoms composed of relatives of the patients and hospital staff. Within 
these samples, OBE occurred in 14% of the patients and 5% of the control group (Lopez & 
Elzière, 2017).  
In the non-clinical population, cortical hyperexcitability has been suggested as a potential 
neural correlate of OBE (Braithwaite et al., 2013a). Given the interplay between neural 
excitation : inhibition ratio and perception, investigation of perception can be a useful 
method to investigate cortical excitation and inhibition in humans (see Dickinson, Jones, & 
Milne, 2016; Heeger, Behrmann, & Dinstein, 2017 for reviews). For example, some people 
experience discomfort including headache and nausea, and see perceptual distortions such 
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as phantom colours, shimmering and bending of lines, when viewing certain visual patterns 
such as high contrast black and white stripes. This phenomenon has been termed ‘pattern 
glare’ and effects are most pronounced when stimuli are presented at spatial frequencies of 
3 to 4 cycles per degree (Wilkins et al., 1984). Viewing images of this nature can lead to 
paroxysmal epileptiform EEG activity in people with photosensitive epilepsy (Wilkins, Binnie, 
& Darby, 1980), and pattern glare symptoms are reported more frequently in individuals 
who experience migraine with aura (Huang, Cooper, Satana, Kaufman, & Cao, 2003). Both 
migraine and epilepsy have been associated with elevated cortical excitability (Welch, 
D'andrea, Tepley, Barkley, & Ramadan, 1990), supporting the suggestion that pattern glare 
is due to cortical hyperexcitability. Braithwaite and colleagues found that people who had 
an OBE reported increased pattern glare compared with people who had not (Braithwaite et 
al., 2013a; Braithwaite et al., 2013b), leading to the suggestion that individual differences in 
cortical excitability may underlie OBE in the non-clinical population (Braithwaite et al. 2013). 
Further support for this position comes from subsequent work which showed that in a 
group of clinically healthy student volunteers, participants who experienced increased 
pattern-glare showed increased response to cortical excitation, delivered via anodal tDCS 
stimulation and decreased response to cortical inhibition delivered via cathodal stimulation 
(Braithwaite, Mevorach, & Takahashi, 2015).  
In addition to experiencing pattern glare, the participants in Braithwaite’s studies who had 
OBE, and / or experienced increased pattern glare, reported increased experience of other 
types of anomalous, hallucinatory perception, as measured with the Cardiff Anomalous 
Perception Scale (CAPS). The CAPS is a 32-item self-report questionnaire which asks 
participants whether or not they have experienced a range of anomalous perceptions, such 
as “Do you ever have the sensation that your limbs might not be your own or might not be 
properly connected to your body?” and “Do you ever feel that someone is touching you, but 
when you look nobody is there?” Significantly more of these items were endorsed by people 
who had experienced an OBE than people who had not (Braithwaite et al., 2013a) 
suggesting that the neural substrate underlying propensity to OBE in the non-clinical 
population may give rise to a variety of anomalous perceptual experiences.  
There are a number of different ways that cortical hyperexcitability could manifest in 
individuals with OBE. Drawing on fMRI data showing that migraineurs with aura show 
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elevated BOLD response in the visual cortex when viewing stimuli that elicit pattern glare 
compared to non-migraineurs, Huang et al. (2003) have suggested that migraineurs with 
aura experience an imbalance in the excitatory neurotransmitter glutamate and the 
inhibitory neurotransmitter GABA (Huang et al., 2003). This neuronal imbalance may cause 
neurons to fire inappropriately leading to aura and visual distortions such as pattern glare 
(c.f. Braithwaite et al., 2013a; Braithwaite et al., 2013b). Additionally, disruption to the 
timing of visual information processing and of the integration of visual information with 
higher level processes could lead to an OBE. As Braithwaite et al., (2013b) point out: “The 
coherent sense of embodiment rests on a coordinated set of inputs from various sensory 
regions of the brain. If certain information is not available for integration at the correct time, 
or it is available but degraded in some way, then the integrative processes will seek to 
combine whatever compromised information is available- possibly resulting in a form of 
illusory conjunction …” (Braithwaite et al., 2013b, pp 553). 
The aim of the current study is to use EEG to further understand the neural dynamics of 
people who experience OBE. The EEG signal recorded at the scalp reflects a finely tuned 
balance between neural excitation and inhibition (Bruyns-Haylett et al., 2017), and enables 
measurement of stimulus-related perturbations in neural activity with sub-millisecond 
precision, as such, the technique of EEG is very well suited to test the hypotheses that 
variation in cortical excitability, and / or disruption in the timing of visual information 
processing may be associated with OBE in the non-clinical population.  
Following presentation of a visual stimulus, the ERP waveform takes on a characteristic 
appearance with identifiable peaks and troughs known as the P1-N1 complex. Increases in 
both EEG power and phase-locking are also seen, particularly in the alpha frequency band (8 
– 13 Hz). Phase-locking can be quantified by computing inter-trial coherence (ITC). This 
variable, which is measured between 0 and 1, reflects the consistency of phase-angles 
across trials at any given time point in a time-series. Within the EEG signal, high ITC indicates 
consistent phase locking and has been considered to reflect stable neural networks, 
whereas lower ITC indicates reduced consistency of phase-locking and more noisy and 
unstable networks (see David et al., 2016). Reduced phase locking is likely to exert a 
functional effect on perception and cognition and may give rise to timing errors of the type 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
described by Braithwaite et al. (2013b). One aim of this study is therefore to test the 
hypothesis that people who have had a spontaneous OBE will have lower ITC than people 
who have not had a spontaneous OBE.  
In addition to alpha phase-locking, a number of other EEG variables can provide insight into 
the integrity of neural networks underlying visual information processing. For example, 
visual alpha-band oscillations are considered to play a functional role in controlling the 
timing of information processing. According to one influential theory (Klimesch, Sauseng, & 
Hanslmayr, 2007), the P1 component of the visual evoked potential represents the 
inhibitory-phase of the alpha-oscillation which acts as an inhibitory filter, increasing signal to 
noise ratio during stimulus encoding and facilitating top-down integrative processes. 
Measuring P1 amplitude in people who have and have not had an OBE will provide insight 
into the emergence of networks combining bottom-up and top-down influences (Hanslmayr, 
Sauseng, Doppelmayr, Schabus, & Klimesch, 2005; Klimesch et al., 2007). Furthermore, 
presentation of a visual stimulus is associated with an increased in the power of higher 
frequency, gamma-band, oscillations, i.e. between 30 and 90 Hz (Schadow et al., 2007). 
Gamma-band oscillations are generated by the activity of inhibitory GABAergic interneurons 
in neuronal networks involving excitatory pyramidal cells and inhibitory interneurons 
(Bartos, Vida, & Jonas, 2007; Traub et al., 1998; Whittington & Traub, 2003). The peak 
frequency of visually induced gamma-oscillations has been shown to be related to levels of 
the inhibitory neurotransmitter GABA in the visual cortex (Muthukumaraswamy, Edden, 
Jones, Swettenham, & Singh, 2009; Cousijn et al., 2014). Specifically, higher peak frequency 
of visually induced gamma oscillations is associated with elevated resting occipital GABA 
levels. Differences in the frequency of the visual induced gamma-band response between 
people who have and have not had an OBE may therefore be indicative of an association 
between OBE and variation in the balance of neural excitation and inhibition. 
Here we recorded EEG during visual stimulation from people who either have, or have not, 
had a spontaneous OBE. We computed three main variables of interest: P1 ERP amplitude; 
the consistency of alpha phase-locking following stimulus presentation (ITC); and the peak 
frequency of induced gamma oscillations. We hypothesised that people who have had a 
spontaneous OBE would show reduced P1 ERP amplitude, reduced alpha-band inter-trial 
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coherence, and lower peak induced gamma-frequency, than those who have not had a 
spontaneous OBE. We also computed power spectral density obtained from eye-closed 
resting data in order to compare baseline power between groups. Participants were 
recruited on the basis of whether or not they had ever had an OBE, and were free of any 
neurological, neurodevelopmental or psychiatric diagnoses. 
2. Method 
2.1 Participants 
Participants were recruited from the student and staff body at the University of Sheffield in 
the UK and via social media. 551 participants completed an online screening questionnaire 
hosted by Qualtrics (www.qualtrics.com), which consisted of the questions presented in 
table 1. From this screening questionnaire, participants who met the inclusion and none of 
the exclusion criteria were invited to an EEG session based on whether or not they had had 
an OBE. Inclusion criteria for the OBE group were: participant had experienced one or more 
OBE, defined by answering ‘yes’ to Q1 of the screening questionnaire and confirmed during 
the lab session; and participant was over 18. Exclusion criteria for the OBE group were: 
history of migraines, epilepsy or seizures; a diagnosis of bipolar disorder, psychosis or 
schizophrenia; diagnosis of a neurodevelopmental condition; currently taking medication 
which may affect neurotransmitter balance (e.g. medication for anxiety / depression, or 
opiate based medication); reporting that the OBE occurred whilst under the influence of 
drugs or alcohol; or providing a description of an OBE that occurred during sleep, which is 
indicative of a lucid dream. Inclusion criteria for the control group were: responding ‘no’ to 
question 1 of the screening questionnaire, and being the same gender and within +/- 2 years 
of an OBE participant’s age. Exclusion criteria for the control group were: medical history of 
migraines, epilepsy or seizures; diagnosis of a neurodevelopmental condition; diagnosis of 
bipolar disorder, psychosis or schizophrenia; or currently taking medication which may 
affect neurotransmitter balance.   
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
Table 1 - OBE screening questionnaire 
 
 Question Response Options 
1 Have you ever had an experience where you have perceived / experienced the world from a 
vantage point outside of the physical body? If NO, please skip to Q7. If YES:  
Yes/No/DK 
 
1a Did you see a representation of your physical body? Yes/No/DK 
1b Did you see the world from a perspective outside of your physical body? Yes/No/DK 
1c Did you feel detached from the body? Yes/No/DK 
1d Did you feel in control of your experience(s)? Yes/No/DK 
1e How long do you estimate the experience(s) lasted? Scale of 1 (≤1) – (≥ 30 min) 
2 How frequently do the experiences occur? 1 (once) - 5 (very frequently) 
3* Did the experience occur while you were asleep? Yes/No/DK 
4* Do you think the experience occurred as a result of drinking alcohol or from medication (either 
prescription or recreational)? 
Yes/No/DK 
5 When you have had these experiences, have they been associated with any particular time of your 
life? 
Free response 
6 Please describe these experiences in as much detail as you can. If you have had many, please 
describe the most common type. 
Free response 
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7* Do you experience any of the following conditions: migraine, epilepsy, seizure? Yes/No/DK 
8* Do you have a diagnosis of any neurodevelopmental condition? (e.g. autism, ADHD) Yes/No/DK, please provide detail 
9* Do you have a diagnosis of any mental health condition? (e.g schizophrenia, bipolar disorder) Yes/No/DK, please provide detail 
10 Do you experience frequent episodes of dizziness? Yes/No/DK, please provide detail 
11 Do any of your first-degree relatives have a diagnosis of any neurodevelopmental condition? (e.g. 
autism, ADHD) 
Yes/No/DK, please provide detail 
12 Do any of your first-degree relatives have a diagnosis of any mental health condition? (e.g. 
schizophrenia, bipolar disorder) 
Yes/No/DK, please provide detail 
 
* = exclusion criteria 
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All participants who completed the screening questionnaire were entered into a prize draw 
to win a £50 Amazon voucher. Each participant who came into the lab for the testing session 
was given £5 as a gesture of our thanks for their time. The study received full ethical 
approval from the local research ethics committee. Participants provided informed written 
consent, in accordance with the declaration of Helsinki. 
A total of thirty-nine people took part in the EEG study, 19 participants who reported a 
spontaneous OBE and twenty participants who had never had an OBE.  The OBE group (14 
females, 5 males) had a mean age of 26.8 years (SD = 10.2) the control group (14 females, 6 
males) had a mean age of 26.5 years (SD = 9.7), the mean age of the two groups was not 
significantly different, Mann-Whitney U = 182, p = .832, r = .042.  
2.2 Measures & Procedure 
2.2.1 Questionnaires 
During the lab-based session the experimenter asked participants to describe their previous 
OBE (where applicable) to ensure that the description matched the inclusion criteria and did 
not fulfil any of the exclusion criteria. Participants completed the Cardiff Anomalous 
Perceptions Scale (CAPS, Bell, Halligan, & Ellis, 2005). Participants responded to each 
question with Yes/No (coded 1/0 respectively). The minimum possible score was 0 and the 
maximum possible score was 32.  Participants also completed the Autism Spectrum 
Quotient (AQ, Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001), which is a 50 
item questionnaire that measures the degree to which adults report traits associated with 
the autistic phenotype. Each of the 50 items is scored as 0 or 1, with 1 being indicative of a 
response associated with an autistic-like trait.  The AQ was administered as we have 
previously found  that autism is associated with reduced alpha-band ITC (Milne, 2011) and 
elevated induced gamma-band frequency (Dickinson, Bruyns-Haylett, Smith, Jones, & Milne, 
2016), and that autistic adults obtain higher CAPS scores than neurotypical controls (Milne, 
Dickinson, & Smith, 2017). We therefore included the AQ so that autistic traits could be 
accounted for by analyses of covariance if necessary.   After completion of the 
questionnaires, EEG was recorded.  
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2.2.2 EEG Task 
Participants were seated inside an electrically shielded chamber and asked to sit still and 
watch the computer screen. Stimuli were generated by the Psychtoolbox set of functions 
(Brainard & Vision, 1997) and presented on a 20-inch LCD screen within Matlab (The 
Mathworks inc.). Stimuli consisted of a black and white checkerboard which subtended 13.5 
x 11.5 degrees of visual angle, presented at a distance of 57cm. Each check subtended 0.4 
degrees of visual angle. Participants were asked to maintain fixation on a small red cross 
that appeared in the centre of the checkerboard and remained present during the inter-
stimulus interval. Each checkerboard remained on screen for a mean interval of 2000 ms, 
jittered between 1500 and 2500 ms. The mean inter-stimulus interval was also 2000 ms, 
jittered between 1500 and 2500 ms. Two blocks of 100 trials were presented, the length of 
break between block 1 and block 2 was determined by the participant, and was typically 
under two minutes. Participants were instructed to press the spacebar at stimulus offset. 
Responses were made with the right hand in the first block and the left hand in the second 
block. After delivery of 200 trials, resting state data were acquired. Participants remained 
seated with the EEG cap in place and, when ready, were asked to close their eyes while EEG 
was recorded for 75 seconds.  
2.3 EEG recording and pre-processing 
EEG data were recorded from 64 electrodes via the BioSemi ActiveTwo system (Amsterdam, 
The Netherlands). Channel offsets were kept below +/-25 kΩ. EEG data were filtered online 
with a band-pass of 0.01-140 Hz and digitised with BioSemi ActiView software at a sampling 
rate of 2048 Hz. Offline processing was carried out using EEGLAB (Delorme & Makeig, 2004) 
and customised MATLAB (The Mathworks, Inc.) EEG data were downsampled to 512 Hz with 
BioSemi DBF Decimator software. Continuous data were referenced to the central channel 
Cz, and then high-pass filtered using a Hamming windowed finite impulse response filter 
with a passband edge of 1 Hz, to minimise low frequency drift. Following visual inspection, 
portions of data that were contaminated by gross artefacts were deleted. Channels were 
excluded if they showed artefacts or poor connection to the scalp in more than ten trials. 
The remaining data were decomposed by extended infomax ICA using the function runica 
implemented in EEGLAB. Independent components reflecting eye-movement and blinks and 
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clearly artifact-based components were excluded from the data (Delorme and Makeig 2004; 
(Zhao, Valentini, & Hu, 2015). Removed channels were then interpolated. The mean number 
of channels removed within each group was 2.6 (OBE) and 2 (control); the mean number of 
components removed within each group was 6.3 (OBE) and 6.5 (control).   
Following this processing pipeline, continuous data were segmented into different files and 
subjected to additional processing depending on the type of analyses to be performed. 
Task-related data were epoched in two different ways: for ERP analysis, continuous data 
were filtered with a low-pass cut-off of 30Hz, and segmented into epochs with a 100 ms 
baseline and 600 ms post-stimulus period around the onset of stimulus presentation; for 
time/frequency analyses (inter-trial phase coherence and measurement of evoked and 
induced gamma activity), continuous data were segmented into epochs with a -1000 ms 
baseline and a 1500 ms post-stimulus period around the onset of the stimulus, no additional 
filtering was performed. The mean number of epochs retained for each group was 191 (OBE 
group) and 193 (control group).  
Continuous data files recorded during the resting state were re-referenced to common 
average reference and divided into 2 second epochs. No additional filtering was performed. 
2.4 Calculation of EEG variables 
2.4.1 ERPs 
P1 amplitude was extracted for each participant from an ‘average-channel’ - created by 
averaging the waveforms from channels P8, PO8, PO4, O2, P7, PO7, PO3 and O1 (see 
supplementary material). P1 amplitude was calculated by computing the mean amplitude 
between 80 and 130 ms on each trial and then calculating the median of these single-trial 
values for each participant.  
In order to establish whether any observed group differences were specific to P1, N1 and P2 
amplitudes were also computed. Extraction of N1 and P2 amplitudes was carried out exactly 
as described above, using time-windows of 120 to 170 ms (N1) and 200 to 250 ms (P2). The 
selection of electrodes for analysis was informed by identifying the electrodes where P1 was 
most prominent (see Figure 2A). Time-window selection was based on inspection of the 
grand-averaged ERP (see Figure 2B). Furthermore, both channel and time-window selection 
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were informed by, and in-line, with previous publications, e.g. see Im, Liu, Zhang, Chen, & 
He (2006) and Novitskiy et al., (2011).   
2.4.2 Inter-Trial Coherence 
The power spectrum of each trial from the average-channel described above was calculated 
using the newtimef function in EEGLAB (for a detailed description of this method see 
Delorme et al., 2004). The function used wavelets with 3 cycles at the lowest frequency and 
12.5 cycles at the highest frequency with a window size of 556.56 ms. Spectral estimates at 
200 evenly spaced time-points (from -721.5 to 1221.5 ms) and 47 evenly spaced frequencies 
(from 6 to 50Hz) were returned as complex vectors in phase space. After normalising the 
magnitude of each trial activity vector to 1, the complex average of each trial activity vector 
was averaged. ITC values are reported here as absolute values from these complex averages. 
High ITC (maximum = 1) indicates strong phase coherence, i.e., consistent alpha phase 
locking, whereas low ITC (minimum = 0) indicates weak phase coherence, i.e. inconsistent 
alpha phase locking. Time-frequency plots showing ITC at all frequencies across the epoch 
were plotted for each participant. Each participant showed an increase in ITC following 
stimulus presentation between ~50 and ~245 ms, predominantly at lower frequencies. A 
mean ITC value between 8 and 10 Hz and between 50 and 245 ms was computed for each 
participant and used as the dependent variable for subsequent group analysis. 
2.4.3 Visual gamma band response 
In order to avoid the contamination of artifacts such as power line interference at 50 Hz and 
saccadic eye movements in the visual gamma band response, time frequency analysis was 
applied to the timeseries from independent components (ICs) rather than from channels 
(Yuval-Greenberg, Tomer, Keren, Nelken, & Deouell, 2008). From each participant, the IC 
which showed the clearest induced gamma signal was selected for analysis. Component 
selection took place via the following procedure: (1) the seven ICs that accounted for the 
most variance to the ERP between 0 and 600 ms post stimulus onset were identified; (2) 
time-frequency analysis (wavelet transform) was performed on each of the identified ICs; (3) 
each of the resulting spectral plots was visually inspected in order to identify the 
component(s) which showed induced gamma power following stimulus presentation. The 
time frequency data associated with one IC was selected for each subject (as in Dickinson et 
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al., 2016b). If more than one IC within a subject showed a clear induced gamma response, 
the IC with the strongest (i.e. highest amplitude) power was selected. Figure 1 provides an 
example of a resulting time-frequency decomposition from a participant who experienced 
OBE, showing induced power across a large frequency range (left panel), and the same data 
focussed on the gamma range (middle panel). In all cases the scalp maps of each selected 
component showed a similar projection to that depicted in figure 1 (right panel), i.e. to the 
back of the head, indicating that the ICs which showed the clearest visually induced gamma 
response projected strongly to channels positioned above the occipital and parietal cortices.  
An illustrated example of the process of selecting ICs for analysis is given in supplementary 
material.  
The timeseries of the selected ICs from each subject was analysed using wavelet transforms, 
replicating the procedure used in our previous work (e.g. see Dickinson et al., 2016). The 
complex Morlet wavelet (a complex exponential modulated by a Gaussian, ω0= 6; where ω0 
is non-dimensional frequency) was chosen as the function ψ0 because it provides a good 
balance between time and frequency localisation for feature extraction purposes (Grinsted, 
Moore, & Jevrejeva, 2004; Müller et al., 2004). The number of octaves per wavelet scale was 
set at 1/60 which provided a sufficiently ‘smooth’ picture of wavelet power and resulted in 
high spectral resolution in the gamma band range (<1Hz). Mean power for each scale during 
the pre-stimulus period for each trial was considered to be baseline and was subtracted 
from the wavelet transforms. As such, data is presented as changes in power following 
stimulus presentation. For measurement of induced gamma power and frequency wavelet 
transforms were performed on each epoch and then averaged, for measurement of evoked 
gamma power, the single-trial time series were averaged prior to wavelet transform. 
Although our main hypothesis was that the peak frequency of induced gamma oscillations 
would be lower in the participants who had experienced OBE, for completeness, we also 
included analyses of evoked and induced power. Induced power was identified as the 
maximum power within the frequency band of 30 to 90 Hz. To ensure the induced signal 
was selected, the time window was restricted to between 200 to 1450 ms of the average of 
the single-trial wavelet analysis. Peak induced gamma frequency was given as the frequency 
of this maximum power. Evoked power was given as the mean power within the frequency 
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band of 30 to 80 Hz and within the time window of 50 to 200 ms of the averaged trial 
wavelet analysis. 
 
Figure 1 Time frequency decomposition and scalp map of the selected IC from a subject in 
the OBE group. A shows epoch-averaged time frequency analysis of entire frequency range. 
B shows epoch-averaged time frequency analysis of restricted frequency range (Gamma 
30:90 Hz). C shows the scalp map of the independent component (IC) selected for time 
frequency analysis.  
2.4.4 Power spectral density  
Power spectral density value was calculated using EEGLAB function spectopo, which uses 
the pwelch function within Matlab (The Mathworks Inc.) to perform frequency 
decomposition. For analysis, channels from the following four regions were averaged: 
anterior left (including channels AF7, AF3, F7, F5, F3, F1, FT7, FC5, FC3, FC1, T7, C5, C3 and 
C1), anterior right  (AF8, AF4, F8, F6, F4, F2, FT8, FC6, FC4, FC2, T8, C6, C4 and C2), posterior 
left  (TP7, CP5, CP3, CP1, P9, P7, P5, P3, P1, PO7, PO3 and O1), and posterior right  (TP8, CP6, 
CP4, CP2, P10, P8, P6, P4, P2, PO8, PO4, O2). Spectral power was computed from these 
channel-averages, and absolute alpha and gamma power were given as mean power 
between 8 and 13 Hz (alpha) and between 30 and 45 Hz (gamma) at each of the four regions 
of interest. For anlaysis, values were converted to µV^2/Hz by computing 10 ^ (spectrum / 
10). 
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3. Results 
Data were analysed using JASP (version 0.9.0.1). Parametric statistics were used to compare 
groups unless Shapiro-Wilks test of normality indicated that the distribution of data in either 
group was not normally distributed. Effect sizes for group comparisons are given by Cohen’s 
d for normally distributed data and by rank biserial correlation (r) for non-normally 
distributed data. Bayes factors (BF) were also included for analyses that pertained to the 
main hypotheses, i.e. that P1 amplitude would be reduced in the OBE group, that ITC would 
be reduced in the OBE group and that induced gamma frequency would be reduced in the 
OBE group. We adopted the classification scheme reported by JASP, in which a BF between 
1 and 3 provides only anecdotal evidence to prefer the experimental hypothesis over the 
null hypothesis, a BF between 3 and 10 provides moderate evidence, a BF between 10 and 
30 provides strong evidence, and a BF between 30 and 100 provides very strong evidence. 
For all analyses we used default prior scales. For a more in depth discussion of Bayesian 
principles and JASP, see Marsman & Wagenmakers (2017). 
3.1 OBE Screening Questionnaire 
One hundred and thirty-three (24%) of the 551 participants who completed the screening 
questionnaire reported having had an OBE. Note that this incidence rate may be higher than 
would be found in the general population because those who have had an OBE may have 
been more likely to respond to the advertisement to take part in research investigating 
anomalous perception. As reported in table 2, there was no difference between people who 
had had an OBE and people who had not in their reports of migraines (43% and 46%), 
epilepsy (0% and 0.2%) or seizures (3.8% and 3.1%). However there was a significant 
difference in experience of dizziness between those who had and had not experienced an 
OBE, χ²(1, N = 551) = 14.9, p = <.001; a larger percentage of those who reported an OBE 
(35%) experienced dizziness compared to those who did not (21%). Of those who reported 
dizziness, 52% did not know the cause; the most common known causes were low blood 
pressure, anaemia, migraine, vestibular disorders and retinal disease. There was also a 
significant difference between those who had had an OBE and those who had not in their 
report of being diagnosed with a mental health condition, χ²(1, N = 551) = 9.7, p = <.05, with 
a larger percentage of those who had experienced an OBE (39%) reporting a mental health 
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condition compared to those who did not (25%). Of those who reported a mental health 
diagnosis, the most common were anxiety (66%) and depression (54%) followed by bipolar 
disorder (1%) and psychosis (1%).   
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Table 2 - A summary of the results from the OBE screening questionnaire 
 
Question OBE  Non-OBE Group Difference 
Gender 97 Female (72%), 35 
Male, 1 Transgender 
275 Female (66%), 
142 Male, 1 
genderfluid 
χ
2 
= 0.18 
Age (S.D.) 27.1 (9.9) 25.5 (9.9) t = 0.12 
Saw a representation of their physical body 56 (42%) NA  
Saw the world from a perspective outside of their physical body 86 (65%) NA  
Felt detached from the body 95 (71%) NA  
Felt in control of experience(s) 40 (30%) NA  
Length of experience <1min: 42 (32%) 
1-3 mins: 80 (60%) 
>30 mins: 11(8%) 
NA  
OBE occurred during sleep 6 (5%) NA  
OBE occurred as a result of drinking alcohol or from medication 
(either prescription or recreational) 
3 (2%) NA  
Migraine  57 (43%) 195 (46%) χ
2 
= 0.07 
Epilepsy 0 1 (0.2%) χ
2 
= 0.32 
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Seizure 5 (4%) 13 (3%) χ
2 
= 0.14 
Diagnosis of a neurodevelopmental condition (e.g. autism, ADHD) 11 (8%) 47 (11%) χ
2 
= 0.95 
Diagnosis of a mental health condition (e.g schizophrenia, bipolar 
disorder) 
52 (39%) 105 (25%) χ
2 
= 9.7* 
Experience frequent episodes of dizziness 46 (35%) 88 (21%) χ
2 
= 14.9** 
First-degree relatives with a diagnosis of a neurodevelopmental 
condition (e.g. autism, ADHD) 
47 (35%) 34 (8%) χ
2 
= 0.35 
First-degree relatives with a diagnosis of a mental health condition 
(e.g. schizophrenia, bipolar disorder) 
13 (9%) 13 (9%) χ
2 
= 0.20 
 
 
* = p<.05, ** = p<.01 
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The following results pertain only to the participants who came into the lab to take part in 
the EEG session.  
3.2 CAPS and AQ score 
The OBE group obtained significantly higher CAPS scores than the control group (mean = 
11.68, SD = 4.8, range 0 - 22 and mean = 4.8, SD = 5.3, range 3 – 26, respectively), Mann-
Whitney U = 48, p = <.001, r = .747 There was no significant group difference in AQ score 
t(37) = .311, p = .758, d = .099. The AQ score range in the control group was 7-30 (mean = 
17.8, SD = 6.9) and 12-29 (mean = 18.4, SD = 5.5) in the OBE group. As no group differences 
in AQ score were seen, this variable was not used as a covariate in any further analyses. 
3.3 EEG Paradigm 
3.3.1 Accuracy and Reaction Time 
Mean time to respond to stimulus offset was 395.60 (116.33) ms. There was no significant 
difference between response times of the participants who had (M = 426.93, SD = 135.29) 
and had not had an OBE (M = 365.83, SD = 88.36), Mann-Whitney U = 132, p = .107, r = .305. 
Furthermore, there was no significant difference in the number of responses missed by the 
two groups, Mann-Whitney U = 151, p = .203, r = .305. The OBE group missed 4.5 (out of 
200) responses on average and the control group missed 2.5 responses.  
3.3.2 ERP amplitude  
Data from two participants (one from each group) were excluded from ERP analyses as they 
did not show a clear P1 peak within the 80 to 130 ms time-window (the typical latency of 
the first clear peak within the ERP of these participants was ~ 180 ms). P1 amplitude was 
significantly reduced in the OBE group compared to the control group, Mann-Whitney U = 
242, p = .031, r = .415, BF = 4.452. In order to establish whether difference in amplitude 
between the two groups was specific to the P1 deflection we also compared N1 and P2 
amplitudes; no group differences were found: N1: t(35) = 0.469, p = .642, d = .154, BF = 
0.458, P2: t(33) = 1.083, p = .286, d = .356, BF = 0.833. ERP data are shown in Figure 2. 
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Figure 2 ERP results. A shows the distribution of amplitude across the scalp in the OBE group 
(top row) and control group (bottom row) averaged across the specified time-windows 
which correspond to the P1, N1 and P2 deflections. B shows the grand-average ERP from 
the channel average (see method section) in the two groups; the thick lines show the group 
mean and the thin lines show + / 1 one standard error around the mean. C shows box plots 
of mean amplitude for P1 (top), N1 (middle) and P2 (bottom). Note the only significant 
group difference was seen in P1 amplitude.  
3.3.3 ITC 
Time-frequency plots indicated that ITC increased in all participants following stimulus 
presentation, therefore data from all participants were analysed. Alpha-band ITC was 
significantly lower in the participants who had experienced OBE than those who had not, 
t(37) =2.515, p = .016, d = .806, BF = 6.738. Time-frequency plots averaged across the OBE 
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and control groups, alongside box-plots showing the distribution of mean ITC values are 
shown in figure 3. 
 
Figure 3. ITC results. A and B show average time-frequency plots of ITC in the control (A) 
and OBE groups (B) as computed from the channel average. The box-plot in C shows ITC 
data in both groups computed as mean ITC between 50 and 245 ms and between 8 to 10 Hz. 
3.3.4 Visual Gamma Band 
There was no significant difference between the OBE and control group in any of the 
variables calculated from the visual gamma band response. Mean (and SD) evoked gamma 
power in the OBE and control groups was 2.88 dB (0.66) and 2.93 dB (0.57), Mann-Whitney 
= 196.5, p = .866, r = .034. Mean Induced gamma power was 0.99 dB (0.39) and 1.25 dB 
(0.62), Mann-Whitney = 230, p = .267, r = .211. Mean peak induced gamma frequency was 
57.48 Hz (16.88 Hz) and 57.88 Hz (21.65) in the OBE and control group, Mann-Whitney = 
190.5, p = 1, r = .003, BF = 0.316. Time-frequency plots showing average induced power for 
the OBE and control group are shown in supplementary material. 
3.3.5 Power spectral density 
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Figure 4 shows the mean power spectrum and the scalp-distribution of alpha and gamma 
power in the two groups. Visual inspection of this plot suggested that the two groups may 
differ in alpha and / or gamma power, therefore these frequency bands were investigated 
further. There were no statistically significant differences in alpha power between the 
participants who had and had not experienced an OBE at any of the four regions of interest, 
all t < 1; all p ≥ 0.519, all d ≤ 0.209. There was a significant difference in spontaneous gamma 
power between the two groups when measured over the left anterior region only. 
Specifically, gamma power was lower in the OBE group (mean = 0.07 dB, SD = 0.07), than in 
the control group (mean = 0.14 dB, SD = 0.11), t(37) = 2.390, p = .022, d = .766. However, 
when corrected for multiple comparisons, this difference was no longer significant.  
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Figure 4. Spectral power during eyes-closed rest in the two groups. A shows the power 
spectrum of each group, calculated from the average of all channels. B shows scalp 
topographies of alpha and gamma band power in the control and OBE group.  
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4. Discussion 
The aim of this study was to gain further insight into the potential neural correlates of 
spontaneous OBE that occur in the absence of any known neurological or psychiatric 
condition. Specifically, it has been suggested that OBE may arise from inconsistency in the 
timing of neural activity underlying visual perception, potentially occurring as a result of 
cortical hyper-excitability (Braithwaite et al., 2013b). We recruited healthy participants on 
the basis of whether or not they had experienced a spontaneous OBE, and compared 
visually-elicited EEG and eyes-closed resting-state EEG between the two groups. Participants 
with OBE had smaller P1 amplitude and reduced inter-trial alpha-phase coherence than 
participants without OBE. In line with (Braithwaite et al., 2013a) we also found increased 
report of anomalous perceptual experiences, i.e. increased CAPS scores, in the participants 
with OBE. Contrary to our prediction, we did not find any difference in induced gamma 
frequency between the groups. 
The P1 deflection arises from increased power associated with activation of neural networks, 
and may, in-part, arise from the resetting of on-going alpha phase following stimulus 
presentation (Klimesch, Sauseng, & Gruber, 2009; Makeig et al., 2002). Sources of the P1 
have been localised to the extra-striate cortex (Di Russo, Martínez, Sereno, Pitzalis, & 
Hillyard, 2002), and, functionally, P1 is considered to reflect the encoding and integration of 
bottom-up and top-down visual information. As described in the Introduction, it has been 
proposed that on-going alpha phase controls cortical activation, and the P1 ERP deflection 
reflects the deactivating phase of alpha which acts as an inhibitory filter to increase signal to 
noise ratio during perceptual encoding (Klimesch et al., 2009). Therefore, smaller P1 
amplitude in the OBE group may indicate reduced signal to noise ratio in participants who 
experience OBE. The latency of the P1 (~ 100 ms) occurs at a time when bottom-up signals 
are modulated by top-down influences (Hillyard & Anllo-Vento, 1998). Reduced signal to 
noise ratio in this time period, especially when coupled with reduced alpha phase-locking 
could lead to inaccuracies during stimulus classification and identification, potentially giving 
rise to anomalous perceptual experiences such as spontaneous OBE in clinically healthy 
individuals. Furthermore, the predictive coding model of perception assumes that the brain 
generates predictions about the world by combining prior beliefs with incoming sensory 
signals which are then tested against sensory evidence. One can argue that OBE represents 
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an example of false inference about the state of the self which may reflect predicting coding 
errors; indeed such claims have been made in an attempt to explain some of the cognitive 
and perceptual symptoms of autism and psychosis (Fletcher & Frith, 2009; Van de Cruys et 
al., 2014). Predictive coding is also assumed to underlie the dynamic coordination of neural 
oscillations (Friston, Bastos, Pinotsis, & Litvak, 2015). In particular, there is evidence that 
neuronal signalling of predictions is mediated by alpha oscillations (Bauer, Stenner, Friston, 
& Dolan, 2014). Taken together with the findings reported here, it is possible that reduced 
P1 amplitude and reduced alpha-phase coherence therefore reflect weaker capacity for 
feedback signalling of predictions which results in some people being more likely to 
experience an OBE than others.  
Further support for the claim that disruption to the timing of visual information processing, 
and / or to the strength of the neuronal signalling of predictions, may lead to OBE comes 
from existing evidence that reduced alpha phase-locking occurs in clinical conditions that 
are associated with anomalous perception such as schizophrenia (Shin et al., 2010) and 
autism spectrum conditions (Milne, 2011; Milne et al., 2017). In addition, administration of 
ketamine leads to a reduction of alpha ITC in mice (Saunders, Gandal, & Siegel, 2012) and is 
known to give rise to dissociative experiences such as OBE in humans (Wilkins, Girard, & 
Cheyne, 2011). Such an association between clinical symptoms and pharmacological 
intervention provides strong indication that reduced alpha phase-locking may give rise to 
OBE in the non-clinical population, as well as in clinical cases.  
The groups did not differ in baseline alpha power recorded during a period of eyes-closed 
rest, suggesting that differences in alpha oscillations in people with OBE are associated with 
the processing of visual information and / or stimulus triggered phase resetting rather than 
with on-going spontaneous alpha oscillations. Furthermore, neither N1 nor P2 amplitude 
differed between the groups. Following the argument of Klimesch et al., (2009) it is the 
positive phase of the VEP, i.e. the P1, that represents the inhibitory phase of alpha, 
therefore the fact that N1 and P2 amplitude did not differ between the two groups suggests 
that it is the inhibitory phase of alpha that is disrupted in OBE.  
Although the groups did not differ in spontaneous alpha power, there was a trend towards 
reduction of spontaneous gamma power from left frontal electrodes during eyes-closed rest 
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in the participants with OBE. Interestingly, spontaneous frontotemporal gamma power has 
also been associated with lucid dreaming (Voss et al., 2014). However, our results were 
somewhat inconclusive with respect to gamma oscillations as we found no differences in 
visually evoked or induced gamma power or peak induced frequency between participants 
who did and did not experience OBE, and the difference in left-frontal resting gamma power 
was not significant after correcting for multiple comparisons. The data did not support our 
hypothesis that participants with OBE would have lower peak gamma frequency than those 
without OBE suggesting that baseline levels of resting GABA concentration are not different 
between those who have and have not had an OBE. 
Twenty-four per cent of the respondents to the screening questionnaire reported having at 
least one OBE. This is in-line with other studies that have used a similar approach to 
participant recruitment (e.g. Braithwaite et al., 2013a), but higher than studies that have 
used different sampling methods (e.g. Lopez and Elziѐre, 2017 and Blackmore, 1984). Our 
aim was to use the screening questionnaire to identify people who had had OBE in order to 
invite them to take part in the EEG study. This figure therefore cannot be taken as a 
prevalence estimate as we advertised the research as a study investigating unusual 
perceptual experience and may therefore have obtained responses from a 
disproportionately large number of people who are prone to OBE.  
The number of participants who reported having migraines in the screening questionnaire 
was very high, and did not differ between those people who had had an OBE and those who 
had not (see table 1). A migraine incidence rate of ~44% of the sample is higher than 
published prevalence reports, which are typically about 14% (Burch, Loder, Loder, & 
Smitherman, 2015). However, we didn’t provide a strict definition of migraine in the 
questionnaire therefore it is possible that participants over-reported their experience of 
migraine. Nevertheless, if any participant responded yes to this question they were 
excluded from the EEG study. The proportion of people who were diagnosed with a mental 
health condition was higher in those people who had had an OBE group than in those who 
had not.  Furthermore, more participants in the OBE group than in the control group 
reported experiencing periods of dizziness. This supports previous data showing that 
patients who were being seen in an ontoneurological clinic for dizziness reported higher 
levels of OBE than matched controls (Lopez and Elziѐre, 2017). While all of the participants 
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who took part in the EEG section of this study were free of any clinical diagnosis, some 
participants did report experiencing episodes of dizziness. The cause of these episodes, 
where known, included anaemia and being deficient in vitamin B12.  
Although we screened for overt clinical and / or psychiatric conditions which may be related 
to OBEs, the extent to which the participants who experienced OBEs showed variation in 
psychological correlates that have been associated with OBEs remains unknown. For 
example, OBEs have previously been linked to multisensory own-body processing (Blanke et 
al., 2005) and visuo-spatial perspective taking (see Braithwaite & Dent, 2011; Braithwaite et 
al., 2011); hypomanic excitement (McCreery & Claridge, 1995), and to weak synaesthesia 
(Terhune, 2009). Future work is required to establish to what extent these features may be 
related to the group differences in EEG signals reported here. Furthermore, OBE is not a 
unitary phenomenon. There may be multiple routes to an OBE which arise from disruption 
to different neural and neurocognitive mechanisms. There are also differences in the 
subjective experience of an OBE (see Braithwaite & Dent, 2011 for a discussion). For 
example, while some accounts of an OBE describe the experience as the spontaneous 
perception of the world from a non-physical and external viewpoint, others include 
descriptions of own-body perception from an external viewpoint, and describe an 
experience that can be induced as well as occurring spontaneously. Our selection criteria 
were not nuanced enough to differentiate between potential taxonomies of the OBE, 
however future research would benefit from a more detailed understanding of each 
participants’ specific experiences to identify whether participants fall into particular 
subtypes based on the phenomenology of their experiences, and if so, whether alterations 
to neural dynamics are seen across all subtypes or can be linked with specific experiences.  
5. Conclusion 
To conclude, here we find differences in neural dynamics between healthy participants who 
have had an OBE and participants who have not. The clearest differences between the 
groups were found in the visual alpha response: P1 amplitude and inter-trial alpha phase 
coherence were significantly reduced in the participants with OBE compared to the control 
group. To the best of our knowledge, this is the first report of EEG data obtained from 
clinically healthy people who experience OBE. We propose that inconsistency in the timing 
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and control of visual information processing, mediated by alpha oscillations, represents a 
neural vulnerability for OBE in the non-clinical population. 
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